Summary: The DNAJ-PKAc fusion kinase is a defining feature of fibrolamellar carcinoma (FLC). FLC tumors are notoriously resistant to standard chemotherapies. with aberrant kinase activity assumed to be a contributing factor. By combining proximity proteomics. https://wholesfoodsboxs.shop/product-category/coffee-substitutes/